Inflammatory disorders

Leukotriene receptor antagonist monotherapy ups asthma control

(HealthDay)—As monotherapy, leukotriene-receptor antagonists (LTRAs) improve asthma control versus placebo, according to a review and meta-analysis published online Sept. 22 in the Annals of Internal Medicine.

page 10 from 22